Wenqing Jiang

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof
- Patent number 12,195,538
- Issue date Jan 14, 2025
- ABL Bio Inc.
- Eunyoung Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof
- Patent number 12,173,070
- Issue date Dec 24, 2024
- ABL Bio Inc.
- Eunyoung Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-LAG-3 antibodies and uses thereof
- Patent number 11,414,485
- Issue date Aug 16, 2022
- I-MAB BIOPHARMA (HANGZHOU) CO., LTD.
- Lei Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses the...
- Patent number 11,261,259
- Issue date Mar 1, 2022
- I-MAB BIOPHARMA US LIMITED
- Wenqing Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding agonist for treatment of neurological and other disorders
- Patent number 11,078,287
- Issue date Aug 3, 2021
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- Tejinder Kaur Bhinder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-LAG-3 antibodies and uses thereof
- Patent number 10,577,421
- Issue date Mar 3, 2020
- I-MAB
- Lei Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding agonist for treatment of neurological and other disorders
- Patent number 9,914,781
- Issue date Mar 13, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Tejinder Kaur Bhinder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES
- Publication number 20240287208
- Publication date Aug 29, 2024
- CONCEPT TO MEDICINE BIOTECH CO., LTD.
- Fang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES
- Publication number 20240247073
- Publication date Jul 25, 2024
- CONCEPT TO MEDICINE BIOTECH CO., LTD.
- Fang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES
- Publication number 20240209109
- Publication date Jun 27, 2024
- CONCEPT TO MEDICINE BIOTECH CO., LTD.
- Fang LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE DOMAIN PD-L1 ANTIBODIES
- Publication number 20240209093
- Publication date Jun 27, 2024
- I-Mab Biopharma Co., Ltd.
- Wenqing JIANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF
- Publication number 20230192861
- Publication date Jun 22, 2023
- ABL Bio Inc.
- Eunsil Sung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF
- Publication number 20220363763
- Publication date Nov 17, 2022
- ABL BIO INC.
- Eunyoung PARK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CLAUDIN 18.2 AND ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THE...
- Publication number 20220348675
- Publication date Nov 3, 2022
- I-MAB Biopharma US Limited
- Wenqing Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF
- Publication number 20220056136
- Publication date Feb 24, 2022
- ABL BIO INC.
- Eunyoung PARK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING AGONIST FOR TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS
- Publication number 20210347902
- Publication date Nov 11, 2021
- GlaxoSmithKline Intellectual Property Development Limited
- Tejinder Kaur BHINDER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CLAUDIN 18.2 AND ANTI-4-IBB BISPECIFIC ANTIBODIES AND USES THE...
- Publication number 20210317224
- Publication date Oct 14, 2021
- I-MAB Biopharma US Limited
- Wenqing Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING AGONIST FOR TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS
- Publication number 20200165345
- Publication date May 28, 2020
- GlaxoSmithKline Intellectual Property Development Limited
- Tejinder Kaur BHINDER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-LAG-3 ANTIBODIES AND USES THEREOF
- Publication number 20200071403
- Publication date Mar 5, 2020
- I-MAB Biopharma US Limited
- Lei Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-LAG-3 ANTIBODIES AND USES THEREOF
- Publication number 20190225687
- Publication date Jul 25, 2019
- I-MAB
- Lei Fang
- C07 - ORGANIC CHEMISTRY

Wenqing Jiang

Person

Patents Grantslast 30 patents

Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof

Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof

Anti-LAG-3 antibodies and uses thereof

Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses the...

Binding agonist for treatment of neurological and other disorders

Anti-LAG-3 antibodies and uses thereof

Binding agonist for treatment of neurological and other disorders

Patents Applicationslast 30 patents

TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES

TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES

TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES

SINGLE DOMAIN PD-L1 ANTIBODIES

ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF

ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF

ANTI-CLAUDIN 18.2 AND ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THE...

ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF

BINDING AGONIST FOR TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS

ANTI-CLAUDIN 18.2 AND ANTI-4-IBB BISPECIFIC ANTIBODIES AND USES THE...

BINDING AGONIST FOR TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS

ANTI-LAG-3 ANTIBODIES AND USES THEREOF

ANTI-LAG-3 ANTIBODIES AND USES THEREOF